| Factor Information | |
|---|---|
| Data ID | 3723 |
| Factor | Duration of heart failure (months) |
| Description | Mean HF duration was shorter in Group I (3.6 ± 3.9 months) compared with Group II (25 ± 33 months, p < 0.05). |
| Biomarker | NA |
| Classification | A3 (clinical factor - disease & symptom) |
| Association | |
|---|---|
| Application | prognosis |
| Objective | Risk factor analysis for pre-transplant mortality |
| p Value | <0.05 |
| Conclusion | Seventy-one percent of patients listed with CHD survived to transplant.Younger age at listing and rapid onset of HF were significant risk factors for pretransplant mortality. |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 694 |
| CHD Type | isolated CHD/non-isolated CHD |
| CHD Subtype | PA, IVS/TA/TA/TS/HLHS/PA, VSD/TC/LSOD/ASD/CACA/TA/ECD/TOF/other |
| Reference | |
|---|---|
| PMID | 12581762 |
| Year | 2003 |
| Title | Outcome of children with end-stage congenital heart disease waiting for cardiac transplantation. |
| Sample | ||
|---|---|---|
| Population | children | |
| Source | N/A | |
| Region | New York, USA | |
| Method | N/A | |
| Race | American | |
| Disease History | N/A | |
| Treatment History | Cardiac Transplantation | |
| Group | Died waiting(Treatment) | Transplanted(Control) |
| Number | 12 | 29 |
| Age | Mean age: 2.6 ± 4 years Median age: 0.36 | Mean age: 9.1 ± 7 years Median age: 8.6 |
| Gender (Male: Female) | N/A | N/A |
| Marker Level | 3.6 ± 4.0 months | 25 ± 33 months |
